Last week, Oscar Health Inc. (NYSE:OSCR) reported second-quarter revenue of approximately $2.86 billion, compared to $2.2 billion in the same period the previous year, missing the consensus estimate of $2.91 billion.
The sales increase was primarily driven by higher membership, partially offset by an increase in net risk adjustment transfer accrual.
